Katherine A. Markel

Katherine Markel is an attorney in Holland & Knight's Tysons office, where she focuses her practice on mergers and acquisitions (M&A). She represents acquirers and targets from a wide range of industries, including government contracts, banking, information technology and software services. Ms. Markel routinely drafts purchase agreements and spearheads diligence in complex transactions, and she has conducted in-person negotiations. In addition to her M&A practice, she counsels clients on commercial transactions and general corporate and securities matters, including private placements and venture capital investments.

Ms. Markel brings a unique perspective to the firm and its representation of corporate clients. Prior to joining Holland & Knight, she served as an associate general counsel for a rapidly growing venture-backed technology company in Seattle, Wash. Through this experience, Ms. Markel gained a first-hand understanding of the unique concerns faced by growing companies, which has allowed her to offer practical advice to the firm's clients. She also practiced in the corporate group at a law firm in Seattle where she focused on representing clients in highly regulated industries.

Since joining the firm, Ms. Markel has assisted in the following representative matters: 

• representation of private equity-backed government contractor in acquisition of intelligence solutions company and subsequent $475 million sale of entire platform 
• representation of consulting services company in $75 million sale to a private equity firm 
• representation of public company in multiple acquisitions of cybersecurity and intelligence solutions companies 
• representation of healthcare management company in $35 million sale to large healthcare insurance company 
• representation of cybersecurity government contractor in $65 million sale to another government contractor 
• representation of early stage startup in convertible debt offering and equity investments 
• representation of software technology company in $310 million sale to a private equity firm